Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607

Watchlist Manager
Shanghai Pharmaceuticals Holding Co Ltd Logo
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Watchlist
Price: 20.06 CNY -0.05% Market Closed
Market Cap: 57.1B CNY
Have any thoughts about
Shanghai Pharmaceuticals Holding Co Ltd?
Write Note

Shanghai Pharmaceuticals Holding Co Ltd
Investor Relations

Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs.

On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.

Show more
Loading
601607
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Mr. Qiuhua Yang
Executive Chairman
No Bio Available
Mr. Bo Shen CPA
President, CFO, Head of the Accounting Department & Executive Director
No Bio Available
Mr. Yongzhong Li
VP & Executive Director
No Bio Available
Mr. Ming Dong
Executive Director
No Bio Available
Mr. Tao Zhong
VP, Board Secretary & Joint Company Secretary
No Bio Available
Ms. Shuai Shao
Vice President
No Bio Available
Dr. Shunjiang Yu
Chief Medical Officer
No Bio Available
Ms. Pui Kiu Wong
Joint Company Secretary
No Bio Available
Ying Ke
Director & General Manager of R&D Management Center
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Shanghai Pharmaceutical Mansion, No.200 Taicang Road
Contacts
+862163730908.0
www.sphchina.com